The munine bleomycin model. Nevertheless, linkage of TNF expression and specific leukocyte recruitment has not been previously demonstrated. We were able to detect bioactive TNF but not MIP-ia in lavage fluid of mice 6 h after bleomycmn challenge unpublished observations ; . Furthermore, elevated TNF protein and mRNA has been previously detected 3-8 days postchallenge, establishing that TNF is increased before both the early 2 day ; and late i6 day ; MIP-ia peaks [i2, 21]. Supporting these results, normal lavage cells from CBA J mice express MIP-la protein after stimulation with TNF in vitro. Recent experiments in our laboratories suggest that TNF is a stimulus for MIP-ia expression in vivo. In CBA J mice treated with soluble TNF receptor we detected an 80% reduction of MIP-ia protein 2 days postbleomycin chal. Tres, there was an extensive assessment of ways in which TIF could support Sri Lanka's Ministry of Health in its efforts to strengthen prevention and treatment prgrammes. Main conclusions included TIF's commitment to support the organ.

3. Piguet, P. F., C. Ribaux, V. Karpuz, G. E. Grau, and Y. Kapanci. 1993. Expression and localization of tumor necrosis factor- and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 143: 651. 4. Broekelmann, T. J., A. H. Limper, T. V. Colby, and J. A. McDonald. 1991. Transforming growth factor 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 88: 6642. 5. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor- in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5: 155. 6. Martinet, Y., W. N. Rom, G. R. Grotendorst, G. R. Martin, and R. G. Crystal. 1987. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317: 202. 7. Antoniades, H. N., M. A. Bravo, R. E. Avila, T. Galanopoulos, J. Neville-Golden, M. Maxwell, and M. Selman. 1990. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 86: 1055. 8. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1990. Tumor necrosis factor cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170: 655. 9. Piguet, P. F., and C. Vesin. 1994. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7: 515. 10. Ortiz, L. A., J. Lasky, G. Lungarella, E. Cavarra, P. Martorana, W. A. Banks, J. J. Peschon, H. L. Schmidts, A. R. Brody, and M. Friedman. 1999. Up-regulation of the p75 but not the p55 TNF- receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am. J. Respir. Cell Mol. Biol. 20: 825. 11. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72: 3666. 12. Old, L. J. 1985. Tumor necrosis factor TNF ; . Science 230: 630. 13. Vassalli, P. 1992. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10: 411. 14. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093. 15. Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor TNF ; at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193: 427. 16. Oshiba, A., E. Hamelmann, K. Takeda, K. L. Bradley, J. E. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin Ig ; E and IgG1 in mice. J. Clin. Invest. 97: 1398. 17. Fujiwara, M., Y. Ishida, N. Nimura, A. Toyama, and T. Kinoshita. 1987. Postcolumn fluorometric detection system for liquid chromatographic analysis of amino and imino acids using o-phthalaldehyde N-acetyl-L-cysteine reagent. Anal. Biochem. 166: 72. 18. Lesslauer, W., H. Tabuchi, R. Gentz, M. Brockhaus, E. J. Schlaeger, G. Grau, P. F. Piguet, P. Pointaire, P. Vassalli, and H. Loetscher. 1991. Recombinant soluble tumor necrosis receptor proteins protect mice from lipopolysaccarideinduced lethality. Eur. J. Immunol. 21: 2883. 19. Liu, J., M. W. Marino, G. Wong, D. Grail, A. Dunn, J. Bettadapura, A. J. Slavin, L. J. Old, and C. C. Bernard. 1998. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4: 78. 20. Ruddle, N. H., C. M. Bergman, K. M. McGrath, E. G. Lingenheld, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172: 1193. 21. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltser, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331. 22. Kuwano, K., N. Hagimoto, M. Kawasaki, N. Nakamura, K. Shirakawa, T. Maeyama, and N. Hara. 1999. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104: 13. 23. Aoshiba, K., S. Yasui, J. Tamaoki, and A. Nagai. 2000. The Fas Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 162: 695. 24. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. Wong, E. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88: 2830. 25. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenard. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377: 348. 26. Herbein, G., V. Mahlknecht, F. Batliwalla, P. Gregersen, T. Pappas, J. Butler, W. A. O'Brien, and E. Verdin. 1998. Apoptosis of CD8 T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395: 189. 27. Pimentel-Muinos, F. X., and B. Seed. 1999. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11: 783. The other hand, the crypt epithelial cells belong to the renewal system, which constantly proliferates and turns over. The mode of response to DNA damage and the main pathway mediated by p53 appear to differ among these epithelial systems. That is, in the renewal system, either p53-dependent or p53-independent apoptotic cell death and cell cycle arrest play a major role, but in the conditional renewal system and in the resting cells as well, other mechanism s ; mediated by p53 may carry out an essential role, particularly under conditions where cell turnover and proliferation are not enhanced. In this context, it would be of interest to elucidate whether the cycling cells in the lung undergo either p53-dependent or p53-independent apoptotic cell death in response to bleomycin treatment, as do the crypt cells of the small intestine. The frequency of lung cells expressing p53 in the bleomycin-treated wild-type mice was much higher than that of Ki-67-labeled cells. Identification of the type of cells that expressed p53 was not easy, but both replicating cells Clara cells, basal cells, and type 2 alveolar cells ; and nonreplicating cells ciliated cells ; appeared to be labeled by p53 immunostaining. Although the possibility cannot be ruled out that the cycling cells, comprising a very small fraction of the lung cells, undergo apoptotic cell death in response to bleomycin treatment, we were unable to obtain any evidence of apoptotic cell death in the lung by the methods used in the current study. p53 is known to have a variety of functions in the response to DNA damage and other stimuli.1, 3 Several recent studies demonstrated that p53 directly binds to and repairs damaged DNA by catalyzing DNA renaturation and strand transfer.4, 41, 42 Such a function of p53 is presumed to be essential to the response to DNA damage in the conditional renewal system, including the lung cells, and in the resting cell populations, such as the enterocytes of the small intestinal villi, although further study on the response to DNA damage and the roles of p53 and other factors in noncycling cells is needed to confirm this possibility.

Bleomycin vs gallium in the preoperative evaluation of patients with lung cancer BS Polla and D Slosman Chest 1986; 89; 319DOI chest.89.2.319a This information is current as of March 14, 2008 and boniva.
Functions upstream of the IKK complex, does not affect the production of NF-B-related proinflammatory cytokines 16 ; . We therefore examined whether targeted inhibition of IKK reduced the pneumonitis fibrosis induced by bleomycin in mice using a novel IKK inhibitor, IMD-0354. Here we report the profound antifibrotic effects of IMD-0354 achieved via.

Opposed strand breaks constitute a minor component of bleomycin-induced DNA lesions, they may play a major role in mutagenesis 6 ; . This proposal is confirmed by sequence specificity data Table 1 ; , which reveal that some bleomycininduced base substitutions occur at sequence positions which can only be secondary sites of bleomycin attack. Furthermore, at sequence positions where potential primary and secondary sites are directly opposed, most 11 15 ; of the substitutions were transversions 9 ; , suggesting that they resulted from bypass of an AP site at the purine secondary site ; rather than the pyrimidine primary site ; at these sequence positions. Since AP sites at these purines occur only in the context of a directly opposed strand break, this result suggests that such bivalent lesions rather than lone AP sites were responsible for most of these mutations. It appears that directly opposed lesions may be more mutagenic than staggered lesions. Bivalent Lesions and Cytotoxicity. Although the evidence is not conclusive, double-strand breaks are believed to be the primary cause of bleomycin-induced cytotoxicity 1 ; . The detailed mechanisms for repair of double-strand breaks are not known, but they could depend critically on the structure of the termini. The cleaved bleomycin-induced AP site represents a unique terminus which preliminary studies suggest is relatively resistant to enzymes that normally remove 3' blocks e.g., E. coli endonuclease IV and exonuclease III ; . Thus, double-strand breaks with this terminus may be particularly difficult to repair and therefore highly cytotoxic and bortezomib. And endothelial cells are the likely sources of the profoundly elevated IL-6 levels, whereas alveolar macrophages are the predominant source of TNF Figs. 1B and 2A ; [12, 13, 3032]. Next, at 1224 h post-challenge, TNF and IL-6 probably synergize to stimulate MIP-1 protein secretion from alveolar macrophages. This putative cytokine network is consistent with the kinetics of TNF, IL-6, and MIP-1 protein expression, and strongly supported by the findings of decreased MIP-1 protein levels after neutralization of TNF and IL-6 in vivo [8]. In contrast to the effects attributable to IL-6 in normal alveolar macrophages, treatment with IL-6 plus TNF or bleomycin did not significantly affect MIP-1 expression in lavage cells isolated from animals challenged 8 days previously with bleomycin. Addition of bleomycin to this already maximally stimulated cell population probably had a toxic effect, whereas addition of exogenous IL-6 was probably insignificant given the levels of IL-6 detected in vivo at this time point. TNF alone was the only treatment that stimulated a modest but significant increase in MIP-1 production from the 8-day lavage cell cultures. Supporting the finding of the modest effect of TNF on these cultures, fibroblasts grown out of arthritic lesions and alveolar macrophages isolated from mice previously challenged with mineral dust also secreted only very modest amounts of MIP-1 in response to stimulation with TNF [27, 28]. The cells isolated from these inflammatory lesions were already significantly activated, possibly accounting for the modest increases in MIP-1 protein expression observed in response to additional stimuli. Supporting this contention, levels of MIP-1 secreted from the untreated control group of lavage cells isolated from bleomycin-challenged animals were 10 times higher than MIP-1 levels secreted from the control group of normal alveolar macrophages isolated from animals not challenged with bleomycin. Although these results suggest the lavage cells isolated 8 days after bleomycin challenge are a poor target for the evaluation of potential stimuli of MIP-1 expression in vitro, the modest effects attributable to TNF support the hypothesis that it is one of the stimuli for MIP-1 protein expression late 816 days ; during the response to bleomycin challenge. CO N C The ve Actinidia species varied in seasonal patterns of carbohydrate concentrations in leaves, fruit and ne roots. There were dierences both in total sugar and starch concentrations as well as those of individual sugars and myo-inositol. These observed dierences may reect adaptive survival strategies under varied natural environmental conditions. Delayed owering after bud break, faster carbohydrate accumulation during early fruit development and smaller nal fruit size in the cold-hardy species A. arguta and A. polygama are features which would be advantageous in environments subject to late spring frosts and potentially curtailed summer seasons. The extended period between fruit drop and leaf fall in A. arguta, and increased concentrations of carbohydrate in roots while fruit are still on the vine in A. polygama are further attributes ensuring the availability of more carbohydrate for storage in roots required for survival over extended winters. The dierences in carbohydrate partitioning between the species in fruit during development warrant further investigation in relation to possible underlying dierences in activities of enzymes involved in sucrose-, hexose- and starch partitioning. Furthermore, studies are required to elucidate the role of elevated hexoses and myoinositol in fruit, and whether these compounds are indeed involved in turgor maintenance. To this end, it also needs to be determined whether elevated sugars coincide with the main cell expansion phase in species other than A. deliciosa and bosentan.
Female C57B6 and CBA J mice 6 8 wk old ; were purchased from The Jackson Laboratory Bar Harbor, ME ; . Mice were maintained in specific pathogen-free conditions and provided with food and water ad libitum. To induce pulmonary fibrosis, mice were treated with intratracheal bleomycin Blenoxane, a gift from Bristol Myers, Evansville, IN; 0.15 U kg ; on day 0 as previously described 12, 14 ; . Control animals received only sterile saline as previously described 12, 14 ; . Briefly, mice were anesthetized with 250 l of 12.5 g ml ketamine injected i.p. followed by intratracheal instillation of 0.025 U of bleomycin in 25 l sterile isotonic saline. At 2, 8, 12, and 20 days postinstillation, animals were euthanized, and both lungs were removed for homogenization as described below. In separate experiments bleomycin-treated mice were given daily i.m. injections of recombinant IP-10 1 g in 20 0.25% HSA ; or HSA 20 l 0.25% HSA ; until day 12. Mice were sacrificed on day 12 for hydroxyproline assay.

DNA are in excess, so that the is proportional to the concento bleomycin.5 the bleomycin When assay applied does not and buspirone.
UNION MEMORIAL HOSPITAL HAND FELLOWSHIP PROGRAM IS ACCEPTING APPLICATIONS OF CANDIDATES WHO HAVE COMPLETED TRAINING IN GENERAL PLASTIC, OR ORTHOPAEDIC SURGERY, FOR THE ACADEMIC YEAR JULY 1, 1985 to JUNE 30, 1986. THESE APPLICATIONS WILL BE REVIEWEDAND INTERVIEWS ARRANGED IN DECEMBER, 1983 and JANUARY, FEBRUARY AND MARCH, 1984. PLEASE ADDRESS REQUESTS FOR APPLICATIONS TO MS LOIS BRANDENBURG, OFFICE MANAGER, CURTIS HAND CENTER, THE UNION MEMORIAL HOSPITAL, 201 E. UNIVERSITY PARKWAY, BALTIMORE, MD 21218 OR TELEPHONE 301 ; 235-7200, extension 2774. There must be no evidence of disseminated cancer Patients must have clinical stage T1N1M0; T2-4, N any, M0. The only exception would be for patients with malignant supraclavicular or celiac nodes who are considered eligible irrespective of the site of esophageal primary [Appendix III], but patients with a TE fistula or direct invasion into the mucosa of the trachea or major bronchi are not eligible ; . Pre-entry CTs of chest and abdomen are required MRIs are acceptable ; . An imaging study suspicious for liver metastases must be followed with a negative liver biopsy before a patient can be considered eligible to enter the study. Zubrod Performance Status 0-1 Appendix II ; Patients' total intake oral enteral ; must be 1700 kCal day see Section 4.1.10 ; Platelet count must be 150, 000 mm., Hgb 10 gm%, and ANC 1500. Serum creatinine 1.5 mg dl and or calculated creatinine clearance 65cc min; if both are done, both must be within these limits. Bronchoscopy with biopsy and cytology if lesion is seen ; is required, to exclude TE fistula if the primary carcinoma is 26 cm from the incisors. Bronchoscopy is also required when the cancer is at or above the carina by an imaging study. Patient must not have had a second malignancy, other than curable non-melanoma skin cancer or cervical cancer in situ, unless disease-free for 5 years. Medical and Radiation Oncologist Evaluations should be performed prior to randomization. All patients must sign the study-specific informed consent prior to randomization. Ineligibility Criteria Prior chest radiotherapy; prior systemic chemotherapy; prior major esophageal surgery; Patients with multiple primary carcinomas of the esophagus; Failure to perform the studies specified in Section 4.1 with findings consistent with the criteria noted; Due to the embryotoxic effects of chemotherapy, pregnant or lactating women or men unable or unwilling to practice contraception are excluded. Patients with an uncontrolled diabetes, heart disease, or hypertension; Patients who are unable to comprehend the study requirements or who are not likely to comply with the study parameters and busulfan and bleomycin. Prednisone or doxorubicin + bleomycin + vinblastine + dacarbazine abvd.
Koch's Postulates the causative agent must be present in every case of the disease and must not be present in healthy animals. the pathogen must be isolated from the diseased host animal and must be grown in pure culture. the same disease must be produced when microbes from the pure culture are inoculated into healthy susceptible animals. the same pathogen must be recoverable once again from this artificially infected animal and it must be able to be grown in pure culture. Koch's postulates not only proved the germ theory but also gave a tremendous boost to the development of microbiology by stressing a laboratory culture and identification of microorganisms. Circumstances under which Koch's postulates do not easily apply Many healthy people carry pathogens but do not exhibit the symptoms of disease. These "carriers" may transmit the pathogens to others who then may become diseased. Example: epidemics of certain hospital acquired nosocomial ; infections, gonorrhea, typhoid, pneumonia, and AIDS. Some microbes are very difficult to grow under in-vitro in the laboratory ; conditions. Example: viruses, chlamydia, rickettsias, and bacteria that cause leprosy and syphilis. Some of the fastidious organisms can now be grown in cultures of human or animal cells or in small animals. Not all laboratory animals are susceptible to all pathogens. Many pathogens are species specific. Ethical considerations limit the use of laboratory animals and human volunteers. Certain diseases develop only when an opportunistic pathogen invades a susceptible host. These secondary invaders or opportunists cause disease only when a person is ill or recovering from another disease. For example, in the case of pneumonia and ear infections following influenza, isolation of bacteria-causing pneumonia may mislead the isolation of influenza virus. Not all diseases are caused by microorganisms. Many diseases are caused by dietary deficiencies scurvy, rickets ; . Some of the diseases are inherited or are caused by abnormality in chromosomes. Still others, such as cancer of the lungs and skin, are influenced by environmental factors. Cells Robert Hooke observed small empty chambers in the structure of cork with the help of his crude microscope. He called them cells. With the help of advanced microscopes it is now known that a cell is composed of many different substances and contains tiny particles called organelles that have important functions. Two German biologists Matthias Schleiden and Thedore Schwann proposed the "Cell theory' in 1838. According to this theory, all living things are composed of cells and butorphanol.
Calcium Channel Blockers Verapamil 80 mg BID to TID or 120 mg day - 240 mg day sustained release Diltiazem 120 mg day - 180 mg day TID or sustained release Flunarizine 10 mg day investigational in U.S. ; Anticonvulsants Divalproex 250 mg - 750 mg BID to TID Gabapentin 300 mg - 1200 mg BID to TID Topiramate 25 mg - 150 mg BID. Very Small a % Vitamin Products b % Herbal Products c # Vit Identity Tests d # Herb Identity Tests e Cost of a Test f # Batches g Finished Batches Currently Being Tested h Batches Requiring Testing 1-g ; i Manufacturing Fraction j Cost Per Firm a * c ; + Firms In FDA Survey l % of Industry in FDA Survey m Industry Cost j * k ; l 24% 76% 1.97 .67 223 34.2% Small 42% 58% 1.97 .67 554 58.3% Large 69% 31% 1.97 .67 309 75.6.

ABSTRACT: The purpose of this study was to determine the characteristics of intestinal absorption and metabolism of 5-aminosalicylic acid 5ASA ; . Regional perfusions of 5ASA in the anesthetized rat resulted in the appearance of N-acetyl-5-aminosalicylic acid in the intestinal lumen. Lumenal metabolite appearance was proportional to 5ASA permeability, which was 5-fold higher in the jejunum than in the ileum. Intestinal elimination significantly decreases 5ASA absorption at low lumenal drug concentrations and this process is saturated at high drug concentrations. Metabolite levels in intestinal tissue were higher than plasma levels at low perfusion drug concentrations, whereas the reverse was observed at high concentrations. Transport and metabolism of 5ASA was studied in Caco-2 monolayers. At low drug concentrations, 5ASA was preferentially transported in the basolateral BL ; to apical AP ; direction. With 5ASA incubation in either the AP or BL chamber, the N-acetyl metabolite appeared only in the AP compartment. Transport of N-acetyl-5-aminosalicylic acid was also exclusively observed in the BL to AP direction. Clinical data indicate that antiinflammatory response to oral 5ASA correlates with the amount of 5ASA delivered to the intestinal tissue. This study shows that at lumenal levels below 200 g ml concentrations that are typically achieved by controlled release dosage forms ; , intestinal secretion of 5ASA accounts for more than 50% of the total elimination and can significantly affect tissue levels and, therefore, may be an important factor in determining the response to 5ASA therapy and boniva. Presented here tested the hypothesis that the transcription factor, early growth response factor-1 Egr-1 ; , is required for inflammation to occur in the liver during cholestasis. The results of these studies show that Egr-1 was rapidly upregulated primarily in hepatocytes in mice subjected to bile duct ligation, an animal model of cholestasis. To determine whether Egr-1 was required for inflammation and hepatocyte injury during cholestasis, bile duct ligation was performed in wild-type and Egr-1 knockout mice. Hepatocyte injury, neutrophil accumulation, and upregulation of macrophage inflammatory protein-2 MIP-2 ; and intercellular adhesion molecule-1 ICAM-1 ; in the liver were significantly reduced in Egr-1 knockouts. By contrast, levels of tumor necrosis factor-alpha TNF- ; and collagen i.e., a biomarker of liver fibrosis ; were not different between wild-types and Egr-1 knockouts subjected to bile duct ligation. Since hepatocytes are exposed to elevated concentrations of bile acids during cholestasis, it was determined whether bile acids upregulate Egr-1 in primary mouse hepatocytes. Deoxycholic acid dose.

1. Every step of the Pop Idol journey has been a battle for Michelle 2. McManus. Everyone agreed that the girl had a great voice, but, as 3. Simon Cowell put it at the final 100 stage, "You're standing in front of a 4. sign that says Pop Idol. That's where we have a problem." She certainly 5. didn't fit the mould of your stereotypical skinny pop star. And with Foxy 6. knocking her appearance week in, week out and Pete Waterman 7. proclaiming, "You're not a Pop Idol. You'll never be a Pop Idol, " it looked 8. as though size-20 Michelle really wouldn't make it through to the final 9. stage of the competition.
Other factors may have increased the confounding effect, however, the factors included in our sensitivity analyses were considered potentially strong confounders. Nevertheless, they were not able to explain the primary study findings. The data from these linked medical records show, as in the main cohort study, that there are differences between the aprotinin and aminocaproic acid patients with respect to characteristics that influence risk of study outcomes such as redo CABG ; . Strong correlation is evident between the data from the medical records and the administrative data with respect to data elements that are common to them. Since there exist differences between the aprotinin and aminocaproic acid groups with respect to the medical record data and the medical record data is only partially represented in the administrative data, there will exist some residual imbalance between aprotinin and aminocaproic acid when adjustment is made using the administrative data only as was done for the main cohort study ; . We accounted for the residual differences between the medical records data and the administrative data and developed projections of the effect that the misclassified administrative covariate measures could have on our results and conclude that the residual differences are insufficient to offer a complete explanation of the results from the main cohort study analysis. Indeed, accounting for the differences between the data from the two sources had only limited effect on the results. The present data underscore the robustness of the original analysis and offer a refutation of the hypothesis that the difference in dialysis and mortality outcomes observed among aprotinin users relative to aminocaproic acid users is due to incomplete capture of covariates in the administrative Premier data. A limitation of this medical record abstraction effort and the analyses based on the resulting data is that these data come from a single institution out of the many that contributed data to the full cohort analysis. This fact limits the generalizability of this analysis accounting for differences between medical records data and administrative data. Although accounting for the more detailed covariate data obtained from medical records from this one institution made minimal difference, it is possible to hypothesize that more of a difference might be observed if data from other institutions were included. However, this single institution was a large referral institution representing numerous surgeons and a variety of preferences with respect to aprotinin or aminocaproic acid use. Therefore, this sensitivity analysis provides a reasonable impression of the magnitude of the residual confounding that may be present in the main study based on administrative data only. The ability of this study to obtain medical record data on a subset of the patients in the main cohort study establishes the feasibility of this process, and means that medical record abstraction efforts could be employed to address any remaining uncertainty about the quality of the Premier administrative data and analyses based on them. The sensitivity analysis could not explain the primary study findings despite the fact that it tended to overestimate any bias, because it assumed that all bias estimates were independent of patient factors already adjusted for in the main analysis and because it was assumed that each bias estimate is independent from each other and would add up for the net confounding. Since the regression model in the primary database analysis already adjusted for 41 covariates with good model prediction c 0.8 ; it is likely that the. The group mas a p p John and l i c Sack r e a down .and f e e stoniach. Something' s--wrong. SACK I d o good. SEC. CLEARY i g n Sack ; T h a good p r o Let me mention something t o t Commerce s e c. It can appear from 24 hours to 9 weeks of administration of bleomycin and usually resolves after discontinuation of the drug.